Wedbush Analyst Reiterates Confidence in Kura Oncology with Outperform Rating and 37 Price Target
Wedbush analyst Robert Driscoll has once again expressed his confidence in Kura Oncology (NASDAQ: KURA), giving it an "Outperform" rating ...
Wedbush analyst Robert Driscoll has once again expressed his confidence in Kura Oncology (NASDAQ: KURA), giving it an "Outperform" rating ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.